Ticker Details
LifeMD, Inc. Common Stock
IPO Date:	February 1, 2008
Sector:	Healthcare
Industry:	Health Information Services
Market Cap:	$160.97M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.23 | 3.77%
Avg Daily Range (30 D):	$0.11 | 3.22%
Avg Daily Range (90 D):	$0.11 | 3.27%

Institutional Daily Volume
Avg Daily Volume:	.66M
Avg Daily Volume (30 D):	1.17M
Avg Daily Volume (90 D):	1.05M

Trade Size
Avg Trade Size (Sh.):	115
Avg Trade Size (Sh.) (30 D):	117
Avg Trade Size (Sh.) (90 D):	124

Institutional Trades
Total Institutional Trades:	203
Avg Institutional Trade:	$1.63M
Avg Institutional Trade (30 D):	$.99M
Avg Institutional Trade (90 D):	$.85M
Avg Institutional Trade Volume:	.17M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.88M
Avg Closing Trade (30 D):	$.99M
Avg Closing Trade (90 D):	$.85M
Avg Closing Volume:	197.12K

News

Mar 31, 2026 @ 6:35 PM Slash Your Wegovy Costs: Novo Nordisk Reveals Firs... Source: Vandana Singh

Mar 24, 2026 @ 8:05 PM LifeMD Declares Quarterly Dividend on Series A Cum... Source: Globe Newswire

Jan 5, 2026 @ 5:23 PM Novo Nordisk's Wegovy Weight Loss Pill Hits US Pha... Source: Vandana Singh

Dec 26, 2025 @ 1:00 PM LifeMD Declares Quarterly Dividend on Series A Cum... Source: Na

Nov 17, 2025 @ 6:01 PM Novo Nordisk Leans Into Affordability Amid Rising ... Source: Vandana Singh

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$.25		$.25
Diluted EPS	$.25		$.25
Revenue	$194.06M	$7.08M	$194.06M
Gross Profit	$166.34M	$2.85M	$166.34M
Net Income / Loss	$15.62M	$19.94M	$15.62M
Operating Income / Loss	$-7.67M	$-6.22M	$-7.67M
Cost of Revenue	$27.71M	$4.23M	$27.71M
Net Cash Flow	$1.78M	$13M	$1.78M
PE Ratio	13.96

Splits
Oct 14, 2020	1:5